Evidence map›Paper›PMID 37762621›Full record

ReviewInternational journal of molecular sciences2023

Alpha-Linolenic Acid and Cardiovascular Events: A Narrative Review.

Camilla Bertoni, Martina Abodi, Veronica D'Oria, Gregorio P Milani, Carlo Agostoni, Alessandra Mazzocchi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Recent advances and future directions on GLA-producing organisms.Frontiers in bioengineering and biotechnology · 2025
    Review
  20. α-ALA Attenuates Cardiac Injury in Diabetic Heart Disease Mice by Modulating Inflammation and AMPKα1.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Camilla BertoniDepartment of Veterinary Sciences for Health, Animal Production and Food Safety, University of Milan, 20122 Milan, Italy.
Martina AbodiDepartment of Veterinary Sciences for Health, Animal Production and Food Safety, University of Milan, 20122 Milan, Italy.ORCID 0000-0002-6272-5336
Veronica D'OriaPediatric Area, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Gregorio P MilaniPediatric Area, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.ORCID 0000-0003-3829-4254
Carlo AgostoniPediatric Area, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.ORCID 0000-0002-5006-0832
Alessandra MazzocchiDepartment of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
University of Milan · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · IT

Funding

Ministero della Salute 2021 Grant for IRCCS
6 · The paper itself

Abstract

Cardiovascular diseases (CVDs) represent the leading cause of global mortality with 1.7 million deaths a year. One of the alternative systems to drug therapy to minimize the risk of CVDs is represented by alpha-linolenic acid (ALA), an essential fatty acid of the omega-3 series, known for its cholesterol-lowering effect. The main purpose of this review is to analyze the effects of ALA and investigate the relevant omega-6/omega-3 ratio in order to maintain functionally beneficial effects. Concerning the lipid-lowering preventive effects, ALA may favorably affect the values of LDL-C and triglycerides in both adult and pediatric populations. Furthermore, ALA has shown protective effects against hypertension, contributing to balancing blood pressure through customary diet. According to the 2009 EFSA statement, dietary ALA may contribute to reducing the risk of CVDs, thanks to anti-hypertensive, anti-atherosclerotic and cardioprotective effects.

Indexed as

Cardiovascular DiseasesFatty Acids, Omega-3HypertensionAdultalpha-Linolenic AcidAntihypertensive AgentsChildHumansalpha-Linolenic AcidAntihypertensive AgentsFatty Acids, Omega-3alpha-linolenic acidcardioprotective effectcardiovascular eventsheart disordershempseed oilLDL-cholesterollinoleic acidTC-cholesterol

Identifiers

PMID37762621
PMCPMC10531611
OpenAlexW4386879582

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.